ahk-cu topical Cosmetic/Topical 1g Ampules 3 favorece la circulación sanguínea Wanting to try topical AHK-CU/GHK-CU

The compound contains: A heterocyclic core structure Multiple functional groups that enhance its binding capabilities A molecular weight optimized for drug-like properties These structural characteristics of SLU-PP-332 play a significant role in its interactions with biological targets and its overall pharmacological profile

Patients who are truly deficient receive the treatment they need including injections when clinically warranted and patients who are not deficient are guided toward more appropriate solutions

Your doctor will determine the appropriate schedule based on your specific condition and response

Status Not FDA-approved as of July 30, 2026